Rabia Aziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rabia Aziz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Firdaus Jawed
Department of Physiotherapy, Jamia Hamdard, Room Number 522, 5th floor, Central Library Building, New Delhi, 110062 India
5 shared publications Sohrab Ahmad Khan
Jamia Hamdard, India
4 shared publicationsFirdaus Jawed
Jamia Hamdard, India
3 shared publications- Sohrab Ahmad Khan
Department of Physiotherapy, Jamia Hamdard University, New Delhi, India
3 shared publications - Sumbul Ansari
Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia (A Central University), New Delhi, India
3 shared publications Habiba Sundus
Jamia Hamdard University, India
2 shared publications
Latest Publications
- 22 January 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (1) , 41
Gut microbiota, sarcopenia, and type 2 diabetes: a triangular pathophysiological network
Type 2 diabetes mellitus (T2DM), sarcopenia, and gut microbiota dysbiosis are increasingly recognized as interrelated conditions. T2DM accelerates muscle wasting through insulin resistance, inflammation, and oxidative stress, while sarcopenia worsens metabolic dysfunction. This review explores the interconnected conditions of Type 2 Diabetes, sarcopenia, and gut microbiota dysbiosis, highlighting their therapeutic potential and the need for interventions targeting these conditions for metabolic and musculoskeletal health. An extensive literature search was performed in PubMed, EMBASE, Scopus, and Web of Science up to July 2025 using terms related to gut microbiota, sarcopenia, and T2DM. Both preclinical and human studies were included if they addressed microbial composition, metabolites, inflammation, insulin resistance, or muscle protein turnover. Evidence indicates bidirectional relationships: T2DM patients show higher prevalence of sarcopenia, while reduced muscle mass increases T2DM risk. Gut dysbiosis in T2DM is characterized by depletion of SCFA-producing taxa (e.g., Faecalibacterium prausnitzii) and enrichment of endotoxin-producing bacteria, leading to systemic inflammation and impaired insulin signaling. Germ-free and antibiotic-treated rodent models demonstrate muscle atrophy, whereas probiotic or prebiotic supplementation restores muscle mass and improves glucose metabolism. Limited clinical trials suggest dietary fibre, probiotics, and fecal microbiota transplantation improve glycemic control and inflammatory markers, with potential secondary benefits on muscle function. T2DM, sarcopenia, and gut microbiota are linked through insulin resistance, inflammation, and altered signaling. Targeting gut-muscle-metabolism axis through diet, microbiota modulation, and exercise is promising. Future longitudinal and interventional studies are needed to establish causality and develop precision microbiome-based therapies. Type 2 diabetes mellitus (T2DM), sarcopenia, and gut microbiota dysbiosis are interconnected in a triangular pathophysiological network. T2DM accelerates muscle loss through insulin resistance, inflammation, and oxidative stress, while sarcopenia worsens glycaemic control. Gut dysbiosis reduces beneficial short-chain fatty acid (SCFA) production and increases pro-inflammatory metabolites such as lipopolysaccharides, further impairing muscle metabolism and glucose regulation. Preclinical and emerging clinical evidence shows that dietary fibre, probiotics, and fecal microbiota transplantation can modulate this axis. Targeting the gut-muscle-metabolism triad offers promising integrative strategies for preventing and managing diabetic sarcopenia.
- 22 January 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (1) , 41
Gut microbiota, sarcopenia, and type 2 diabetes: a triangular pathophysiological network
Type 2 diabetes mellitus (T2DM), sarcopenia, and gut microbiota dysbiosis are increasingly recognized as interrelated conditions. T2DM accelerates muscle wasting through insulin resistance, inflammation, and oxidative stress, while sarcopenia worsens metabolic dysfunction. This review explores the interconnected conditions of Type 2 Diabetes, sarcopenia, and gut microbiota dysbiosis, highlighting their therapeutic potential and the need for interventions targeting these conditions for metabolic and musculoskeletal health. An extensive literature search was performed in PubMed, EMBASE, Scopus, and Web of Science up to July 2025 using terms related to gut microbiota, sarcopenia, and T2DM. Both preclinical and human studies were included if they addressed microbial composition, metabolites, inflammation, insulin resistance, or muscle protein turnover. Evidence indicates bidirectional relationships: T2DM patients show higher prevalence of sarcopenia, while reduced muscle mass increases T2DM risk. Gut dysbiosis in T2DM is characterized by depletion of SCFA-producing taxa (e.g., Faecalibacterium prausnitzii) and enrichment of endotoxin-producing bacteria, leading to systemic inflammation and impaired insulin signaling. Germ-free and antibiotic-treated rodent models demonstrate muscle atrophy, whereas probiotic or prebiotic supplementation restores muscle mass and improves glucose metabolism. Limited clinical trials suggest dietary fibre, probiotics, and fecal microbiota transplantation improve glycemic control and inflammatory markers, with potential secondary benefits on muscle function. T2DM, sarcopenia, and gut microbiota are linked through insulin resistance, inflammation, and altered signaling. Targeting gut-muscle-metabolism axis through diet, microbiota modulation, and exercise is promising. Future longitudinal and interventional studies are needed to establish causality and develop precision microbiome-based therapies. Type 2 diabetes mellitus (T2DM), sarcopenia, and gut microbiota dysbiosis are interconnected in a triangular pathophysiological network. T2DM accelerates muscle loss through insulin resistance, inflammation, and oxidative stress, while sarcopenia worsens glycaemic control. Gut dysbiosis reduces beneficial short-chain fatty acid (SCFA) production and increases pro-inflammatory metabolites such as lipopolysaccharides, further impairing muscle metabolism and glucose regulation. Preclinical and emerging clinical evidence shows that dietary fibre, probiotics, and fecal microbiota transplantation can modulate this axis. Targeting the gut-muscle-metabolism triad offers promising integrative strategies for preventing and managing diabetic sarcopenia.
- 11 December 2025
- Published by Taylor & Francis
- p. 20-42
Recent Advances in Neuromuscular Sciences in Sports
- 11 December 2025
- Published by Taylor & Francis
- p. 20-42
Recent Advances in Neuromuscular Sciences in Sports
- 1 November 2025
- Published by Elsevier in Journal of Bodywork and Movement Therapies
- Vol. 45, 1058-1065
Impact of manual therapy on adhesion related symptoms post abdominal surgery: A systemic review
- 1 November 2025
- Published by Elsevier in Journal of Bodywork and Movement Therapies
- Vol. 45, 1058-1065
Impact of manual therapy on adhesion related symptoms post abdominal surgery: A systemic review
- Open Access
- 26 May 2025
- Published by Elsevier in Surgery Open Digestive Advance
- Vol. 19
Stages of adhesion development: A pathway for development of preventive strategy after abdominal surgery
- 26 May 2025
- Published by Elsevier in Surgery Open Digestive Advance
- Vol. 19
Open AccessStages of adhesion development: A pathway for development of preventive strategy after abdominal surgery
- Open Access
- 18 January 2025
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 32
Comparative analysis of mental health in middle-aged women with type-2 diabetes mellitus and hypothyroidism: A cross-sectional study
- 18 January 2025
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 32
Open AccessComparative analysis of mental health in middle-aged women with type-2 diabetes mellitus and hypothyroidism: A cross-sectional study
- 10 January 2025
- Published by IGI Global Scientific Publishing
- p. 461-488
Application of AI-Driven IoT (Internet of Things) in Musculoskeletal Research
AI-driven and Internet of Things (IoT)-driven musculoskeletal pain research seeks to develop digital health care for pain using sophisticated technologies such as machine learning (ML), AI and Implementation of IoT Reduces and enhances patient outcomes. Musculoskeletal pain assessment incorporates digital healthcare services, providing preferred, financially friendly, and easily accessible mass patient solutions while addressing resource and time constraints AI-powered digital health provides personalized exercise and pain management recommendations -Treatments have the potential to help individuals with musculoskeletal pain Research on the use of AI-powered mHealth (AIM) environments in musculoskeletal pain management and limited. This chapter this paper concludes with arguments supporting further research and development in musculoskeletal pain management. The potential of enhanced, personalized, and easily accessible therapies represents a significant benefit for individuals with musculoskeletal disorders, which can be achieved through collaborative efforts in this dynamic field
- 10 January 2025
- Published by IGI Global Scientific Publishing
- p. 461-488
Application of AI-Driven IoT (Internet of Things) in Musculoskeletal Research
AI-driven and Internet of Things (IoT)-driven musculoskeletal pain research seeks to develop digital health care for pain using sophisticated technologies such as machine learning (ML), AI and Implementation of IoT Reduces and enhances patient outcomes. Musculoskeletal pain assessment incorporates digital healthcare services, providing preferred, financially friendly, and easily accessible mass patient solutions while addressing resource and time constraints AI-powered digital health provides personalized exercise and pain management recommendations -Treatments have the potential to help individuals with musculoskeletal pain Research on the use of AI-powered mHealth (AIM) environments in musculoskeletal pain management and limited. This chapter this paper concludes with arguments supporting further research and development in musculoskeletal pain management. The potential of enhanced, personalized, and easily accessible therapies represents a significant benefit for individuals with musculoskeletal disorders, which can be achieved through collaborative efforts in this dynamic field
- Open Access
- 8 August 2024
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 29
An evaluation of physical performance in collegiate athletes: A randomized controlled trial comparing backward and forward running
- 8 August 2024
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 29
Open AccessAn evaluation of physical performance in collegiate athletes: A randomized controlled trial comparing backward and forward running
- 31 May 2024
- Published by IGI Global Scientific Publishing
- p. 281-308
Wearable IoT Devices in Rehabilitation
Internet of things (IoT) holds great promise as a solution for providing continuous, objective, and comprehensive monitoring, thereby reducing the labour of human care-givers and facilitating clinical decision-making. In the initial phase of the internet of things in rehabilitation, ubiquitous sensors were integrated into rehabilitation programmes. These sensors were used to monitor the movement of patients, assess their progress, and collect data on a variety of physiological parameters. This chapter will describe the evolution of IoT-based rehabilitation, which shifted from stationary sensors to wearable devices in order to provide precise advanced patient care and rehabilitation, using IoT devices in various activities of daily living and also focuses on the ethical considerations of using wearables IoT devices in rehabilitation.
- 31 May 2024
- Published by IGI Global Scientific Publishing
- p. 281-308
Wearable IoT Devices in Rehabilitation
Internet of things (IoT) holds great promise as a solution for providing continuous, objective, and comprehensive monitoring, thereby reducing the labour of human care-givers and facilitating clinical decision-making. In the initial phase of the internet of things in rehabilitation, ubiquitous sensors were integrated into rehabilitation programmes. These sensors were used to monitor the movement of patients, assess their progress, and collect data on a variety of physiological parameters. This chapter will describe the evolution of IoT-based rehabilitation, which shifted from stationary sensors to wearable devices in order to provide precise advanced patient care and rehabilitation, using IoT devices in various activities of daily living and also focuses on the ethical considerations of using wearables IoT devices in rehabilitation.
- 26 April 2024
- Published by IGI Global Scientific Publishing
- p. 241-259
Transforming Healthcare Through Digital Inclusivity
The combination of digital health and artificial intelligence (AI) is driving a significant shift of the healthcare sector in today's age of fast technological innovation. To ensure that people of all ages, backgrounds, and abilities have equal access to high-quality healthcare, digital health and AI advances have the potential to break down traditional barriers. AI has the potential to revolutionise healthcare by enabling individualised treatment plans, improved illness management, and enhanced well-being for individuals. This chapter is a wonderful resource for anybody interested in the promising future of digital health and AI, including researchers, academics, healthcare practitioners, politicians, and tech enthusiasts.
- 26 April 2024
- Published by IGI Global Scientific Publishing
- p. 241-259
Transforming Healthcare Through Digital Inclusivity
The combination of digital health and artificial intelligence (AI) is driving a significant shift of the healthcare sector in today's age of fast technological innovation. To ensure that people of all ages, backgrounds, and abilities have equal access to high-quality healthcare, digital health and AI advances have the potential to break down traditional barriers. AI has the potential to revolutionise healthcare by enabling individualised treatment plans, improved illness management, and enhanced well-being for individuals. This chapter is a wonderful resource for anybody interested in the promising future of digital health and AI, including researchers, academics, healthcare practitioners, politicians, and tech enthusiasts.
- 19 April 2024
- Published by IGI Global Scientific Publishing
- p. 125-142
Innovations in Robotic-Assisted Physiotherapy
Earlier robotic physiotherapy was constricted to specifically gait and movement training, but with recent advancement, it is expanded to dexterous hand and robotic limbs, which are not only improving patient recovery outcomes but also building maximum functional ability. Paradigm shift to incorporating robot assisted physiotherapy in practice requires a comprehensive and detailed knowledge about the same. This chapter embarks on an expedition into the convergence of robotics and physiotherapy, meticulously navigating through the avant-garde technologies and methodologies that are orchestrating a paradigmatic shift in patient care, thereby fostering a person's enhanced outcomes. By illuminating the dynamic interplay of these two domains, this chapter elucidates the transformative potential they hold in revolutionizing patient care, invigorating the trajectory of recovery, and sculpting a landscape of holistic wellness.
- 19 April 2024
- Published by IGI Global Scientific Publishing
- p. 125-142
Innovations in Robotic-Assisted Physiotherapy
Earlier robotic physiotherapy was constricted to specifically gait and movement training, but with recent advancement, it is expanded to dexterous hand and robotic limbs, which are not only improving patient recovery outcomes but also building maximum functional ability. Paradigm shift to incorporating robot assisted physiotherapy in practice requires a comprehensive and detailed knowledge about the same. This chapter embarks on an expedition into the convergence of robotics and physiotherapy, meticulously navigating through the avant-garde technologies and methodologies that are orchestrating a paradigmatic shift in patient care, thereby fostering a person's enhanced outcomes. By illuminating the dynamic interplay of these two domains, this chapter elucidates the transformative potential they hold in revolutionizing patient care, invigorating the trajectory of recovery, and sculpting a landscape of holistic wellness.